Imiquimod chemoprophylaxis for field cancerization in Xeroderma Pigmentosum patients
Published: 1 November 2021| Version 2 | DOI: 10.17632/g2j8nmxys6.2
Contributor:
Lilian RochaDescription
A prospective study to examine topical imiquimod as chemoprophylaxis in Xeroderma Pigmentosum patients describing clinical evolution during 2 years of follow up.
Files
Steps to reproduce
This is a supplementary data to JAAD submission.
Institutions
Universidade de Sao Paulo Hospital das Clinicas
Categories
Dermatology